Nicola A Hanania (Baylor College of Medicine, TX, US) is a valued member of our Editorial Board for US Respiratory & Pulmonary Diseases. He discusses the different types of inhaler systems available for asthma and COPD, recommendations regarding these different delivery platforms and factors to consider when selecting a device for individual patients.
Questions1. Could you give us a brief overview of the different type of inhaler systems for asthma and COPD? (0:11)
2. Could you tell us a little about the latest guideline recommendations regarding these different delivery platforms? (1:39)
3. What factors should be considered when selecting an inhaler device for a patient with asthma or COPD? (2:39)
View Part 2 here.
View Part 3 here.
Speaker disclosure: Nicola A Hanania has received honoraria for serving on advisory boards or as a consultant for Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Novartis, and Sanofi/Regeneron. His institution has received research grant support on his behalf from Boehringer Ingelheim, AstraZeneca, Roche, and GlaxoSmithKline.
Filmed at the American Thoracic Society (ATS) International Conference 2018, San Diego, CA, US, May 2018.